Register a trial

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT02881203




Registration number
NCT02881203
Ethics application status
Date submitted
22/08/2016
Date registered
26/08/2016

Titles & IDs
Public title
Breast Radiotherapy Audio Visual Enhancement for Sparing the Heart
Scientific title
BRAVEHeart - Breast Radiotherapy Audio Visual Enhancement for Sparing the Heart
Secondary ID [1] 0 0
BRAVEHeartV1
Universal Trial Number (UTN)
Trial acronym
BRAVEHeart
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Breast Cancer 0 0
Condition category
Condition code
Cancer 0 0 0 0
Breast

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Devices - Breathe Well
Treatment: Devices - RPM

Experimental: Breathe Well + RPM - Participants will receive Breathe Well audiovisual feedback in addition to the RPM system

Active comparator: RPM - Varian's RPM system is the current standard of care at Royal North Shore Hospital where this trial is to be run.


Treatment: Devices: Breathe Well
Breathe Well is an audiovisual biofeedback device used to assist patients to regulate their breathing whilst undergoing radiation treatment.

Treatment: Devices: RPM
Varian Real-time Position Management (RPM) system
Intervention code [1] 0 0
Treatment: Devices
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Accuracy of Breathe Well
Timepoint [1] 0 0
2 years
Secondary outcome [1] 0 0
Difference in set up times for Breathe Well vs RPM
Timepoint [1] 0 0
2 years
Secondary outcome [2] 0 0
Patient comfort
Timepoint [2] 0 0
2 years
Secondary outcome [3] 0 0
Staff perception of Breathe Well
Timepoint [3] 0 0
2 years
Secondary outcome [4] 0 0
To develop the use of EPID for real time MLC tracking during breast radiotherapy
Timepoint [4] 0 0
2 years
Secondary outcome [5] 0 0
To compare actual and planned doses
Timepoint [5] 0 0
2 years

Eligibility
Key inclusion criteria
* Left-sided breast cancer patients (invasive and in situ)
* Supine positioning of the patients.
* Ability to perform a =20s breath hold
* >18 years old
* An ECOG score in the range of 0 to 2
* Able to give written informed consent and willingness to participate and comply with the study
* Patients must be able to read and complete questionnaires in English
Minimum age
18 Years
Maximum age
No limit
Sex
Females
Can healthy volunteers participate?
No
Key exclusion criteria
* Involvement or at risk regional lymph nodes
* Pregnant / lactating women

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
NA
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
15/09/2018
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
30/09/2022
Sample size
Target
Accrual to date
Final
45
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 0 0
Royal North Shore Hospital - St Leonards
Recruitment postcode(s) [1] 0 0
2065 - St Leonards

Funding & Sponsors
Primary sponsor type
Other
Name
University of Sydney
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Gillian Lamoury, Medicine
Address 0 0
Royal North Shore Hospital
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Yes
What data in particular will be shared?
Anonymised data will be made available to researchers upon request, once evidence of ethical approval has been provided.
When will data be available (start and end dates)?
Available to whom?
Available for what types of analyses?
How or where can data be obtained?


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.


Results not provided in https://clinicaltrials.gov/study/NCT02881203